The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)

E Shelley Hwang,Celia Kaplan,Anna Weiss,Ann Partridge,Ann Partridge,Ann Partridge,Shoshana Rosenberg,Shoshana Rosenberg,Shoshana Rosenberg,Elizabeth Frank,Alastair Thompson,Antonia Bennett,Thomas Lynch,Donna Pinto,Terry Hyslop,Desiree Basila,Deborah Collyar

doi:10.1136/bmjopen-2018-026797

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)

E Shelley Hwang, Celia Kaplan + Show 15 more

Open Access

https://doi.org/10.1136/bmjopen-2018-026797

Copy DOI

Journal: BMJ Open	Publication Date: Mar 1, 2019
Citations: 202	License type: open-access

Affiliation: Duke University, University of California, San Francisco, Dana-Farber Brigham Cancer Center, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Centre for the Observation and Modelling of Earthquakes, Volcanoes and Tectonics, Baylor College of Medicine, University of North Carolina at Chapel Hill

#Guideline Concordant Care #Ductal Carcinoma In Situ + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

IntroductionDuctal carcinoma in situ (DCIS) is a non-invasive non-obligate precursor of invasive breast cancer. With guideline concordant care (GCC), DCIS outcomes are at least as favourable as some other early...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: BMJ Open

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.